OBRIEN MORGAN E 4
4 · Anterix Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
Anterix Inc.ATEX
OBRIEN MORGAN E
DirectorVice Chairman of the Board
Transactions
- Exercise/Conversion
Common Stock
2022-06-15$25.00/sh+25,000$625,000→ 59,313 total - Sale
Common Stock
2022-06-15$40.03/sh−25,000$1,000,775→ 34,313 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-06-15−25,000→ 90,000 totalExercise: $25.00Exp: 2025-01-29→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $40.00 to $40.595. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]The option shares are fully vested.